Stock listing

OTC:HDII Hypertension Diagnostics, Inc. Stock

Follow Hypertension Diagnostics, Inc. into a list and get an email when it puts out news.

Hypertension Diagnostics, Inc. logo
Ticker
OTC:HDII
Asset type
Stock
Exchange
OTC
Currency
USD

Latest news

All Hypertension Diagnostics, Inc. news

Hypertension Diagnostics, Inc. on 6ix

News releases
4 in all · newest Apr 22, 2021 · oldest 2020

Events

QuarterResults
Quarter to Dec 31, 2024Feb 21, 2025
Quarter to Sep 30, 2024Nov 18, 2024
Quarter to Jun 30, 2024Aug 28, 2024
Quarter to Mar 31, 2024May 22, 2024
Quarter to Dec 31, 2023Feb 16, 2024
Q3 2023Nov 3, 2023
Q2 2023Aug 30, 2023
Q1 2023May 17, 2023
Q4 2022Feb 17, 2023
Q3 2022Nov 4, 2022
All 17 quarters
QuarterResults
Q2 2022Aug 31, 2022
Q1 2022May 18, 2022
Q4 2021Feb 18, 2022
Q3 2021Nov 5, 2021
Q2 2021Sep 1, 2021
Q1 2021May 19, 2021
Q4 2020Feb 19, 2021

Open Events

Financials

Annual, in USD

Income statement

LineFY2022FY2022FY2021FY2021FY2020FY2020FY2019FY2017FY2016FY2012
Revenue3.79M3.68M3.57M3.16M
Cost of revenue2.84M2.93M3.02M3.27M
Gross profit954.5K752.4K551.2K-112.0K
Selling, general and administrative917.8K1.02M1.19M
Operating income-121.9K-121.9K-11.0K-11.0K-420.0K-420.0K-403.5K-656.0K-1.36M
Depreciation and amortization167.9K228.5K236.6K36.0K31.3K34.8K107.2K
EBITDA106.6K225.6K-384.0K-372.2K-621.2K-1.25M
Interest expense161.7K158.5K155.4K143.6K
Income before tax-93.2K-93.2K-11.0K-11.0K3.29M3.29M-368.6K-622.0K-1.47M
Income tax-228.0K-237.0K-206.0K166.6K163.3K-65.5K
Net income-93.2K-93.2K-11.0K-11.0K3.29M3.29M-368.6K-622.0K-1.14M
Earnings per share, basic-0.00-0.00-0.00-0.000.020.02-0.00-0.01-0.02

Balance sheet

LineFY2022FY2022FY2021FY2021FY2020FY2020FY2019FY2017FY2016FY2012
Cash and equivalents86.4K86.4K86.4K86.4K285.4K190.2K75.0K
Receivables191.8K191.8K191.8K191.8K371.2K177.3K297.9K
Inventory189.4K189.4K189.4K189.4K186.5K183.6K172.2K
Current assets509.6K509.6K509.6K509.6K883.1K767.0K576.4K
Property, plant and equipment509.5K576.8K678.3K
Total assets1.08M1.08M1.08M1.08M1.49M1.40M1.31M
Accounts payable445.6K445.6K445.6K445.6K422.1K400.2K170.8K
Current liabilities121.9K121.9K1.34M1.34M1.34M1.34M1.69M1.46M654.8K
Long-term debt4.69M4.20M610.6K
Total debt651.3K651.3K775.0K775.0K4.42M4.20M610.6K
Total liabilities121.9K121.9K2.00M2.00M2.12M2.12M6.12M5.66M1.59M
Shareholders' equity-121.9K-913.7K-913.7K-1.04M-1.04M-4.63M-4.26M-288.7K
Shares outstanding284.8M213.1M213.1M149.2M149.2M136.8M136.8M93.3M52.4M54.2M

Cash flow

LineFY2022FY2021FY2021FY2020FY2020FY2019FY2017FY2016FY2012
Cash from operations-892.3K-892.3K-11.0K-11.0K3.49M3.49M-85.9K-384.9K-1.23M
Capital spending0-3000-2.11K-2.03K-1.96K-630.5K
Free cash flow-892.3K-892.3K-11.0K-11.0K3.49M3.49M-88.0K-386.9K-1.86M
Cash from investing572.1K-2.11K-2.11K-1.96K-380.5K
Cash from financing233.7K233.7K11.0K11.0K-3.49M-3.49M183.2K263.8K927.3K
Change in cash-86.4K-86.4K-202.0K95.2K-123.1K-678.8K

Open Financials

Cap table

Built by 6ix from Hypertension Diagnostics, Inc.’s releases

Common shares
284,781,623
Fully diluted
284,781,623

Fully diluted

LineShares
Common shares284,781,623

Share count over time

CountShares
Nov 22, 2026284,781,623

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark N. Schwartz
Other companies: Solidion Technology, Inc. (Lead Independent Director · Since at least Aug 31, 2026); Onfolio Holdings Inc. (Director · Since at least Aug 25, 2022)
Chief Executive Officer, Director · Feb 28, 2006 – Mar 31, 2006 · Past

Open People

Log in to ask 6ix AI your own questions about Hypertension Diagnostics, Inc.